Correlation Between Inhibrx and TNF Pharmaceuticals,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inhibrx and TNF Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and TNF Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and TNF Pharmaceuticals,, you can compare the effects of market volatilities on Inhibrx and TNF Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of TNF Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and TNF Pharmaceuticals,.

Diversification Opportunities for Inhibrx and TNF Pharmaceuticals,

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between Inhibrx and TNF is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and TNF Pharmaceuticals, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TNF Pharmaceuticals, and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with TNF Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TNF Pharmaceuticals, has no effect on the direction of Inhibrx i.e., Inhibrx and TNF Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Inhibrx and TNF Pharmaceuticals,

Given the investment horizon of 90 days Inhibrx is expected to under-perform the TNF Pharmaceuticals,. But the stock apears to be less risky and, when comparing its historical volatility, Inhibrx is 2.2 times less risky than TNF Pharmaceuticals,. The stock trades about -0.09 of its potential returns per unit of risk. The TNF Pharmaceuticals, is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  109.00  in TNF Pharmaceuticals, on October 16, 2024 and sell it today you would earn a total of  36.00  from holding TNF Pharmaceuticals, or generate 33.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Inhibrx  vs.  TNF Pharmaceuticals,

 Performance 
       Timeline  
Inhibrx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
TNF Pharmaceuticals, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TNF Pharmaceuticals, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, TNF Pharmaceuticals, is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Inhibrx and TNF Pharmaceuticals, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inhibrx and TNF Pharmaceuticals,

The main advantage of trading using opposite Inhibrx and TNF Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, TNF Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TNF Pharmaceuticals, will offset losses from the drop in TNF Pharmaceuticals,'s long position.
The idea behind Inhibrx and TNF Pharmaceuticals, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume